Alexandria Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Alexandria Capital's IDXX Position: Q3 2021 in Review
Alexandria Capital reduced its Idexx Laboratories (IDXX) stake by 7.3% in Q3 2021, selling an estimated $67.2K and leaving 1,275 shares worth $793K. The position accounts for 0.07% of the portfolio, ranked #159.
Alexandria Capital first reported a position in IDXX in Q1 2021 and has held it in 3 quarters since. The position peaked at $868K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.
- Alexandria Capital held 1,275 shares of Idexx Laboratories worth $793K as of Q3 2021.
- Alexandria Capital sold 100 Idexx Laboratories shares in Q3 2021, an estimated $67.2K.
- Idexx Laboratories made up 0.07% of Alexandria Capital's portfolio in Q3 2021, its #159 holding.
- Alexandria Capital first reported a position in Idexx Laboratories in Q1 2021 and has held it in 3 quarters since.
- Alexandria Capital's Idexx Laboratories position peaked at $868K in Q2 2021.
- 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.